MAP2K7 and pachyonychia congenita: Single autophagy inhibitors are ineffective in patients with chemotherapy-resistant PC and can be combined with gemcitabine, MEK/ERK inhibitors, and radiation therapy (Wolpin et al., 2014; Bryant et al., 2019; Chen et al., 2021; Yazal et al., 2022).